ロード中...
A phase II study of a modified FOLFOX6 regimen as neoadjuvant chemotherapy for locally advanced gastric cancer
BACKGROUND: We evaluated the efficacy and safety of the modified FOLFOX6 (mFOLFOX6) regimen as a neoadjuvant chemotherapy in gastric cancer patients. METHODS: Seventy-three patients with T2–T4 or N+ were enroled. Preoperative chemotherapy consisted of three cycles of mFOLFOX6. The primary end points...
保存先:
出版年: | Br J Cancer |
---|---|
主要な著者: | , , , , , , , , , |
フォーマット: | Artigo |
言語: | Inglês |
出版事項: |
Nature Publishing Group
2016
|
主題: | |
オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4984457/ https://ncbi.nlm.nih.gov/pubmed/27172250 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2016.126 |
タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|